Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective pilot study of pharmacokinetics and pharmacodynamics of the interaction between tipranavir/ritonavir and raltegravir in HIV-1 infected patients
2008-001611-38Phase 4Active
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of raltegravir, tipranavir and ritonavir in human immunodeficiency virus infection (HIV), sponsored by Hospital Clínic de Barcelona. Primary endpoint: Primary: Pharmacokinetic comparison of raltegravir levels. Started Jun 2008; status: active.
02
Drugs
raltegravirtipranavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2008-001611-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001611-38.